Marie O'Donnell Edinburgh Urological Cancer Group University of Edinburgh Biography Publications Institution JoVE Articles Marie O'Donnell has not added a biography. If you are Marie O'Donnell and would like to personalize this page please email our Author Liaison for assistance. Publications Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study The Journal of Urology. Sep, 2012 | Pubmed ID: 22999998 Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer PloS One. 2012 | Pubmed ID: 22880013 NEMO Inhibits Programmed Necrosis in an NFκB-independent Manner by Restraining RIP1 PloS One. 2012 | Pubmed ID: 22848449 NFκB and Ubiquitination: Partners in Disarming RIPK1-mediated Cell Death Immunologic Research. Dec, 2012 | Pubmed ID: 22477525 Caspase 8 Inhibits Programmed Necrosis by Processing CYLD Nature Cell Biology. Dec, 2011 | Pubmed ID: 22037414 RIP1 Comes Back to Life As a Cell Death Regulator in TNFR1 Signaling The FEBS Journal. Apr, 2011 | Pubmed ID: 21232018 Chronicles of a Death Foretold: Dual Sequential Cell Death Checkpoints in TNF Signaling Cell Cycle (Georgetown, Tex.). Mar, 2010 | Pubmed ID: 20237426 The Tumour Suppressor CYLD is a Negative Regulator of RIG-I-mediated Antiviral Response EMBO Reports. Sep, 2008 | Pubmed ID: 18636086 Ubiquitination of RIP1 Regulates an NF-kappaB-independent Cell-death Switch in TNF Signaling Current Biology : CB. Mar, 2007 | Pubmed ID: 17306544 Renal Scarring Caused by Vesicoureteric Reflux and Urinary Infection: a Study in Pigs Pediatric Nephrology (Berlin, Germany). Jul, 2002 | Pubmed ID: 12172758 Expression of S100A4 Protein is Associated with Metastasis and Reduced Survival in Human Bladder Cancer The Journal of Pathology. Mar, 2002 | Pubmed ID: 11857492 The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina